436 related articles for article (PubMed ID: 33567616)
1. Mechanisms of Resistance to Conventional Therapies for Osteosarcoma.
Marchandet L; Lallier M; Charrier C; Baud'huin M; Ory B; Lamoureux F
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33567616
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms of chemoresistance in osteosarcoma (Review).
He H; Ni J; Huang J
Oncol Lett; 2014 May; 7(5):1352-1362. PubMed ID: 24765137
[TBL] [Abstract][Full Text] [Related]
3. Research progress on the multidrug resistance mechanisms of osteosarcoma chemotherapy and reversal.
Li S; Sun W; Wang H; Zuo D; Hua Y; Cai Z
Tumour Biol; 2015 Mar; 36(3):1329-38. PubMed ID: 25666750
[TBL] [Abstract][Full Text] [Related]
4. New Insights about the Wnt/β-Catenin Signaling Pathway in Primary Bone Tumors and Their Microenvironment: A Promising Target to Develop Therapeutic Strategies?
Danieau G; Morice S; Rédini F; Verrecchia F; Royer BB
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31370265
[TBL] [Abstract][Full Text] [Related]
5. Targeting Molecular Mechanisms Underlying Treatment Efficacy and Resistance in Osteosarcoma: A Review of Current and Future Strategies.
Lilienthal I; Herold N
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32961800
[TBL] [Abstract][Full Text] [Related]
6. Osteosarcoma in Children: Not Only Chemotherapy.
Argenziano M; Tortora C; Pota E; Di Paola A; Di Martino M; Di Leva C; Di Pinto D; Rossi F
Pharmaceuticals (Basel); 2021 Sep; 14(9):. PubMed ID: 34577623
[TBL] [Abstract][Full Text] [Related]
7. An overview of resistance to chemotherapy in osteosarcoma and future perspectives.
Garcia-Ortega DY; Cabrera-Nieto SA; Caro-Sánchez HS; Cruz-Ramos M
Cancer Drug Resist; 2022; 5(3):762-793. PubMed ID: 36176756
[TBL] [Abstract][Full Text] [Related]
8. Current therapeutic strategies and novel approaches in osteosarcoma.
Ando K; Heymann MF; Stresing V; Mori K; Rédini F; Heymann D
Cancers (Basel); 2013 May; 5(2):591-616. PubMed ID: 24216993
[TBL] [Abstract][Full Text] [Related]
9. Targeting autophagy is a promising therapeutic strategy to overcome chemoresistance and reduce metastasis in osteosarcoma.
Liao YX; Yu HY; Lv JY; Cai YR; Liu F; He ZM; He SS
Int J Oncol; 2019 Dec; 55(6):1213-1222. PubMed ID: 31638211
[TBL] [Abstract][Full Text] [Related]
10. The Current and Future Therapies for Human Osteosarcoma.
Lamplot JD; Denduluri S; Qin J; Li R; Liu X; Zhang H; Chen X; Wang N; Pratt A; Shui W; Luo X; Nan G; Deng ZL; Luo J; Haydon RC; He TC; Luu HH
Curr Cancer Ther Rev; 2013 Feb; 9(1):55-77. PubMed ID: 26834515
[TBL] [Abstract][Full Text] [Related]
11. Verteporfin disrupts multiple steps of autophagy and regulates p53 to sensitize osteosarcoma cells.
Saini H; Sharma H; Mukherjee S; Chowdhury S; Chowdhury R
Cancer Cell Int; 2021 Jan; 21(1):52. PubMed ID: 33446200
[TBL] [Abstract][Full Text] [Related]
12. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
13. Role of autophagy in drug resistance and regulation of osteosarcoma (Review).
Pu Y; Wang J; Wang S
Mol Clin Oncol; 2022 Mar; 16(3):72. PubMed ID: 35251623
[TBL] [Abstract][Full Text] [Related]
14. Osteosarcoma: Cells-of-Origin, Cancer Stem Cells, and Targeted Therapies.
Abarrategi A; Tornin J; Martinez-Cruzado L; Hamilton A; Martinez-Campos E; Rodrigo JP; González MV; Baldini N; Garcia-Castro J; Rodriguez R
Stem Cells Int; 2016; 2016():3631764. PubMed ID: 27366153
[TBL] [Abstract][Full Text] [Related]
15. Altered pH gradient at the plasma membrane of osteosarcoma cells is a key mechanism of drug resistance.
Avnet S; Lemma S; Cortini M; Pellegrini P; Perut F; Zini N; Kusuzaki K; Chano T; Grisendi G; Dominici M; De Milito A; Baldini N
Oncotarget; 2016 Sep; 7(39):63408-63423. PubMed ID: 27566564
[TBL] [Abstract][Full Text] [Related]
16. MicroRNAs in osteosarcoma.
Zhang J; Yan YG; Wang C; Zhang SJ; Yu XH; Wang WJ
Clin Chim Acta; 2015 Apr; 444():9-17. PubMed ID: 25661090
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of the Notch signaling pathway in enhancing the efficacy of chemotherapy drugs in osteosarcoma.
Song Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Oct; 45(10):1234-1240. PubMed ID: 33268586
[TBL] [Abstract][Full Text] [Related]
18. Intrinsic resistance to chemotherapeutic agents in murine osteosarcoma cells.
Takeshita H; Kusuzaki K; Ashihara T; Gebhardt MC; Mankin HJ; Hirasawa Y
J Bone Joint Surg Am; 2000 Jul; 82-A(7):963-9. PubMed ID: 10901311
[TBL] [Abstract][Full Text] [Related]
19. Osteosarcoma: review of the past, impact on the future. The American experience.
Jaffe N
Cancer Treat Res; 2009; 152():239-62. PubMed ID: 20213394
[TBL] [Abstract][Full Text] [Related]
20. HSP90AA1-mediated autophagy promotes drug resistance in osteosarcoma.
Xiao X; Wang W; Li Y; Yang D; Li X; Shen C; Liu Y; Ke X; Guo S; Guo Z
J Exp Clin Cancer Res; 2018 Aug; 37(1):201. PubMed ID: 30153855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
